2.39(0.95%) Volume: 412,009 10:08PM EST| Market Cap : 21.48 B | Enterprise Value : 22.39 B | P/E (TTM) : 51.97 | P/B : 106.25 |
|---|
NAS:IDXX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IDXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the three months ended in Sep. 2019, IDEXX Laboratories paid USD 86 Mil more to buy back shares than it received from issuing new shares. It spent {COMPANY->currency_symbol}{NetIssuanceofDebt_last_f} Mil paying down its debt. It paid USD 0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received USD 0 Mil from paying cash dividends to shareholders. It received USD 8 Mil on other financial activities. In all, IDEXX Laboratories spent USD 100 Mil on financial activities for the three months ended in Sep. 2019.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
| IDEXX Laboratories Quarterly Data | ||||||||||||||||||||
| Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | |
| Cash Flow from Financing |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-84.29 | -117.81 | -2.78 | -109.49 | -99.75 |
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
IDEXX Laboratories's Cash from Financing for the fiscal year that ended in Dec. 2018 is calculated as:
| Cash Flow from Financing | (A: {A1}) | ||||||||
| = | Net Issuance of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
| = | -369.319 | + | -256.04 | + | 0 | + | 0 | + | 27.56 |
| = | -598 |
IDEXX Laboratories's Cash from Financing for the quarter that ended in Sep. 2019 is
| Cash Flow from Financing | (Q: Sep. 2019 ) | ||||||||
| = | Net Issuance of Stock | + | Net Issuance of Debt | + | Net Issuance of Preferred Stock | + | Cash Flow for Dividends | + | Other Financing |
| = | -85.975 | + | -22.013 | + | {NetIssuanceofpreferred_last}} | + | 0 | + | 8.237 |
| = | -100 |
Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2019 was -117.806 (Dec. 2018 ) + -2.781 (Mar. 2019 ) + -109.488 (Jun. 2019 ) + -99.751 (Sep. 2019 ) = USD -330 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Cash from financing contains five items:
1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.
IDEXX Laboratories's net issuance of stock for the three months ended in Sep. 2019 was USD -86 Mil. IDEXX Laboratories paid USD 86 Mil more to buy back shares than it received from issuing new shares.
2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
IDEXX Laboratories's net issuance of debt for the three months ended in Sep. 2019 was USD -22 Mil. IDEXX Laboratories spent USD 22 Mil paying down its debt.
3. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
IDEXX Laboratories's net issuance of preferred for the three months ended in Sep. 2019 was USD 0 Mil. IDEXX Laboratories paid USD 0 Mil more to buy back preferred shares than it received from issuing preferred shares.
4. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
IDEXX Laboratories's cash flow for dividends for the three months ended in Sep. 2019 was USD 0 Mil. IDEXX Laboratories received USD 0 Mil from paying cash dividends to shareholders.
5. Other Financing:
Money spent or earned by company from other financial activities.
IDEXX Laboratories's other financing for the three months ended in Sep. 2019 was USD 8 Mil. IDEXX Laboratories received USD 8 Mil on other financial activities.
No Headline
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP